Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 201–300 of 942
Glioblastoma Microenvironment and Cellular Interactions
Crivii, C.-B., Boșca, A. B., Melincovici, C. S., Constantin, A.-M., Mărginean, M., Dronca, E., Suflețel, R., Gonciar, D., Bungărdean, M., & Șovrea, A. (2022) · Cancers · doi:10.3390/cancers14041092 · Cited by 81
“At the same time, it favors the harvesting of M2 macrophages, and by periostin silencing, the inhibition of tumor growth, and the improvement of in vivo survival are achieved [231].”
BackgroundLiu, Y., Li, X., Zhang, Y., Wang, H., Rong, X., Peng, J., He, L., & Peng, Y. (2019) · Oncogene · doi:10.1038/s41388-019-0952-x · Cited by 87
“Previous reports have suggested that POSNT recruited TAMs and that integrin αvβ3 is the key receptor for POSTN in mediating cell migration [40], which is consistent with our research.”
ResultOrganoid Models of Glioblastoma and Their Role in Drug Discovery
Rybin, M. J., Ivan, M. E., Ayad, N. G., & Zeier, Z. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.605255 · Cited by 91
“Another limitation is that GSC cultures are relatively homogeneous and do not, therefore, recapitulate the complex cellular and microenvironmental interactions that are implicated in tumor initiation, invasion, resistance and recurrence (Calabrese et al., 2007; Lathia et al., 2010, 2012; Cheng et al., 2013; Zhou et al…”
BackgroundEpithelial–Mesenchymal Plasticity in Tumor Immune Evasion
Mullins, R. D. Z., Pal, A., Barrett, T. F., Neal, M. E. H., & Puram, S. V. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4370 · Cited by 93
Li, J., Wang, K., Yang, C., Zhu, K., Jiang, C., Wang, M., Zhou, Z., Tang, N., Wang, Q., Wang, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202207067 · Cited by 102
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Kielbassa, K., Vegna, S., Ramirez, C., & Akkari, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02215 · Cited by 80
“GSCs enhance macrophage recruitment from the periphery by producing chemoattractants, such as periostin (93).”
BackgroundBelgiovine, C., Digifico, E., Anfray, C., Ummarino, A., & Torres, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103226 · Cited by 90
“CSCs are a population of tumor cells, which share some features with stem cells, being able to initiate tumorigenesis thanks to their ability for continuous self-renewal and differentiation [37].”
BackgroundMitchell, K., Troike, K. M., Silver, D. J., & Lathia, J. D. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa259 · Cited by 96
Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer
An, Y., & Yang, Q. (2020) · International Journal of Cancer · doi:10.1002/ijc.33408 · Cited by 90
“The macrophages then promote further production of POSTN in ovarian cancer cells through TGF-β, forming a positive feedback loop which promotes ovarian cancer development.(23,24) Tumors have a high glycolysis rate because the tumor cells need to consume a large amount of glucose and release glycolysis products.”
BackgroundYin, Y., Tang, W., Ma, X., Tang, L., Zhang, Y., Yang, M., Hu, F., Li, G., & Wang, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133848 · Cited by 85
Furudate, S., Fujimura, T., Kakizaki, A., Kambayashi, Y., Asano, M., Watabe, A., & Aiba, S. (2015) · Experimental Dermatology · doi:10.1111/exd.12873 · Cited by 82
The multifaceted role of periostin in priming the tumor microenvironments for tumor progression
Cui, D., Huang, Z., Liu, Y., & Ouyang, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2646-2 · Cited by 90
“1 3 malignant outgrowth in the brain [24].”
BackgroundCurcumin changes the polarity of tumor‐associated microglia and eliminates glioblastoma
Mukherjee, S., Baidoo, J., Fried, A., Atwi, D., Dolai, S., Boockvar, J. A., Symons, M. H., Ruggieri, R., Raja, K. S., & Banerjee, P. (2016) · International Journal of Cancer · doi:10.1002/ijc.30398 · Cited by 88
“Using Iba1 staining to identify the activated microglia within the GBM mass (TAMs),(5,22,23) we counterstained with an antibody against Arginase 1 (ARG1), which is highly expressed by the immunosuppressive and tumor-promoting M2-type microglia.(24) Immunohistochemistry (IHC) analysis of GBM sections revealed that the…”
MethodInflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
Chaudhary, R., Scott, R. A. H., Wallace, G. R., Berry, M., Logan, A., & Blanch, R. J. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.3.23 · Cited by 83
Necrotic reshaping of the glioma microenvironment drives disease progression
Markwell, S. M., Ross, J., Olson, C. L., & Brat, D. J. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02401-4 · Cited by 93
“Within the perivascular niche, GSCs secrete chemotactic factors, such as VEGF, FGF, and PDGF, that disrupt the BBB and local vasculature; colony-stimulating factor (CSF) 1, periostin and stromal cell-derived factor (SDF) 1a that facilitate BMDM influx into the TME; and IL1 and IL6 that reprogram macrophages into an im…”
BackgroundImmune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
Dianat‐Moghadam, H., Mahari, A., Salahlou, R., Khalili, M., Azizi, M., & Sadeghzadeh, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02829-9 · Cited by 84
“CSCs niche enriching of C–C motif chemokine 2/5 (CCL2/5), interleukins (ILs), extracellular matrix (ECM) protein periostin, TGF-β, and colonystimulating factor1 (CSF1) facilize the recruitment and polarization of protumorigenic macrophage into immunosuppressive M2 or TAM phenotypes [19, 20].”
BackgroundCircadian regulator CLOCK promotes tumor angiogenesis in glioblastoma
Pang, L., Dunterman, M., Xuan, W., Gonzalez, A. M., Lin, Y., Hsu, W.-H., Khan, F., Hagan, R. S., Müller, W. A., Heimberger, A. B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112127 · Cited by 86
“9 These findings collectively suggest that CLOCK-regulated POSTN is essential for tumor angiogenesis and GBM progression.”
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
Dai, X., Guo, Y., Hu, Y., Bao, X., Zhu, X., Fu, Q., Zhang, H., Tong, Z., Liu, L., Zheng, Y., et al. (2021) · Theranostics · doi:10.7150/thno.54648 · Cited by 89
“Zhang and colleagues found that under a hypoxic microenvironment, the HIF-1a/IL-1b signaling loop between hepatoma cells and TAMs can promote EMT of cancer cells and metastasis [80].”
BackgroundInfluentialAderetti, D. A., Hira, V. V. V., Molenaar, R. J., & Noorden, C. J. F. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.008 · Cited by 85
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.004 · Cited by 75
Insights in the immunobiology of glioblastoma
Strepkos, D., Markouli, M., Κλώνου, Α., Piperi, C., & Papavassiliou, A. G. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01835-4 · Cited by 79
“In mice xenografts, knockdown of periostin was shown to drastically reduce the number of M2like GAMs leading to elevation of the M1 polarized GAMs and inhibition of tumor growth [34].”
BackgroundIn Vitro Glioblastoma Models: A Journey into the Third Dimension
Paolillo, M., Comincini, S., & Schinelli, S. (2021) · Cancers · doi:10.3390/cancers13102449 · Cited by 90
Liu, Q., Zhao, E., Geng, B., Gao, S., Yu, H., He, X., Li, X., Dong, G., & You, B. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04814-9 · Cited by 83
“Many published papers have revealed that TAM density is strongly associated with a poor prognosis in various human cancers [3, 4], including renal cell carcinoma (RCC) [5].”
BackgroundOne microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 81
“Along with the same line, the cooperation between immune system and cancer stem cell has also been delineated with different immune cell type [292] as well as in different contexts of cancer [293].”
BackgroundIntroductory review: periostin—gene and protein structure
Kudō, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2643-5 · Cited by 75
“These TAMs are mainly monocyte-derived macrophages from the peripheral blood, and periostin maintains the M2 subtype of TAMs to accelerate tumor growth by promoting cancer cell survival in GBMs [34].”
BackgroundHuang, H., Wang, C., Liu, F., Li, H., Peng, G., Gao, X., Dong, K., Wang, H., Kong, D.-P., Qu, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0461 · Cited by 74
“Furthermore, the CSC–TAM cross-talk facilitates tumor growth, metastasis, and chemoresistance (19, 20).”
BackgroundPeriostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma
Ratajczak‐Wielgomas, K., Grzegrzółka, J., Piotrowska, A., Gomułkiewicz, A., Witkiewicz, W., & Dzięgiel, P. (2016) · Oncology Reports · doi:10.3892/or.2016.5095 · Cited by 79
Role of myeloid cells in the immunosuppressive microenvironment in gliomas
Locarno, C. V., Simonelli, M., Carenza, C., Capucetti, A., Stanzani, E., Lorenzi, E., Persico, P., Bella, S. D., Passoni, L., Mavilio, D., et al. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.10.002 · Cited by 79
Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
Hu, C., Pang, B., Lin, G., Yu, Z., & Yi, H. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0644-x · Cited by 82
Pang, L., Dunterman, M., Guo, S., Khan, F., Liu, Y., Taefi, E., Bahrami, A., Geula, C., Hsu, W.-H., Horbinski, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01605-y · Cited by 80
Luo, F., Li, H., Ma, W., Cao, J., Chen, Q., Lu, F., Qiu, M., Zhou, P., Xia, Z., Zeng, K., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01112-y · Cited by 83
“During cancer progression, TAMs can be polarized into the M2-like phenotype via cues within the TME [13 – 15].”
BackgroundYin, W., Li, Y., Song, Y. Y., Zhang, J., Wu, C., Chen, Y., Miao, Y., Lin, C., Lin, Y., Yan, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024171118 · Cited by 75
Macrophages and cancer stem cells: a malevolent alliance
Allavena, P., Digifico, E., & Belgiovine, C. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00383-3 · Cited by 86
The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Zhang, X., Zhao, L., Zhang, H., Zhang, Y., Ju, H., Wang, X., Ren, H., Zhu, X. G., & Dong, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1003651 · Cited by 95
“The macrophages in the GBM microenvironment, or GAMs, are mainly divided into two categories: microglia colonized in the brain (11) and macrophages differentiated from bone marrowderived monocytes (12).”
BackgroundMonocyte-neutrophil entanglement in glioblastoma
Friedmann‐Morvinski, D., & Hambardzumyan, D. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163451 · Cited by 78
“Several reports catalogued macrophages in GBM into two functionally extreme states, often referred to in the literature as polarizations: M1 and M2, which differ in terms of receptor expression, effector function, and cytokine and chemokine production (53–55).”
BackgroundCancer stem cells: a potential target for cancer therapy
Qiu, H. Y., Fang, X., Luo, Q., & Ouyang, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1920-4 · Cited by 78
“Recently, GSCs have been found to secrete periostin to recruit monocyte-derived macrophages from the peripheral blood to support tumor growth [106].”
BackgroundTargeting cancer stem cells in the clinic: Current status and perspectives
Annett, S., & Robson, T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.001 · Cited by 70
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
Mattei, V., Santilli, F., Martellucci, S., Monache, S. D., Fabrizi, J., Colapietro, A., Angelucci, A., & Festuccia, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083863 · Cited by 77
The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors
Wasik, A., Ratajczak‐Wielgomas, K., Bądziński, A., Dzięgiel, P., & Podhorska‐Okołów, M. (2022) · Cancers · doi:10.3390/cancers14174225 · Cited by 74
“In addition, Tian et al. [150] demonstrated that POSTN could be an independent prognostic factor in GSCs.”
BackgroundInfluentialMonocyte-mediated Chemotherapy Drug Delivery in Glioblastoma
Wang, C., Li, K., Li, T., Chen, Z., Wen, Y., Liu, X., Jia, X., Zhang, Y., Xu, Y., Han, M. H., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0266 · Cited by 74
Altered microglia and neurovasculature in the Alzheimer's disease cerebellum
Singh‐Bains, M. K., Linke, V., Austria, M. D. R., Tan, A. Y. S., Scotter, E. L., Mehrabi, N. F., Faull, R. L. M., & Dragunow, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104589 · Cited by 78
Glioblastoma multiforme: novel therapeutic targets
Muir, M. T., Gopakumar, S., Traylor, J. I., Lee, S., & Rao, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1762568 · Cited by 76
“that recruits M2 TAMs via the integrin αvβ3 signaling, and disruption of this pathway inhibits glioma progression [76].”
BackgroundZhang, B., Ye, H., Ren, X., Zheng, S., Zhou, Q., Chen, C., Lin, Q., Li, G., Wei, L., Fu, Z., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.005 · Cited by 71
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 75
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway
Fukasawa, K., Kadota, T., Horie, T., Tokumura, K., Terada, R., Kitaguchi, Y., Park, G., Ochiai, S., Iwahashi, S., Okayama, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01745-1 · Cited by 66
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
Tripathy, D. K., Panda, L. P., Biswal, S., & Barhwal, K. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1355242 · Cited by 84
Ngambenjawong, C., Cieslewicz, M., Schellinger, J. G., & Pun, S. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.057 · Cited by 71
Zhang, W., Chen, L., Ma, K., Zhao, Y., Liu, X., Wang, Y., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12207 · Cited by 73
Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
Kumar, R., de Mooij, T., Peterson, T. E., Kaptzan, T., Johnson, A. J., Daniels, D. J., & Parney, I. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179012 · Cited by 75
Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)
Zhang, S., Yang, X., Wang, L., & Zhang, C. (2018) · Oncology Letters · doi:10.3892/ol.2018.8716 · Cited by 91
“Zhou et al (89) and Shi et al (90) found that in Glioblastoma, the periostin (POSTN) preferentially secreted by GSCs could correlates with TAM density in primary GBMs. Silencing POSTN in GSCs can reduce TAM recruitment, inhibit tumor growth, and extend survival of mice bearing GSC-derived xenografts.”
Pathogenetic Features and Current Management of Glioblastoma
Nguyen, H.-M., Guz-Montgomery, K., Lowe, D. B., & Saha, D. (2021) · Cancers · doi:10.3390/cancers13040856 · Cited by 71
Li, Z., Li, H., Zhao, Z., Zhu, W., Feng, P., Zhu, X., & Gong, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1456-9 · Cited by 71
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
Echavidre, W., Picco, V., Faraggi, M., & Montemagno, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051053 · Cited by 75
“In this setting, the interaction between periostin and αvβ3 was found to recruit TAMs in vivo and support tumor growth [71].”
BackgroundMa, T., Hu, C., Lal, B., Zhou, W., Ma, Y., Ying, M., Prinos, P., Quiñones‐Hinojosa, A., Lim, M. K., Laterra, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2489 · Cited by 67
“GSCs also have been shown to recruit immunosuppressive cells such as anti-inflammatory M2 macrophages, regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSC) by modulating cytokine/chemokine expression, and thus suppress innate immunity (5).”
BackgroundContribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
Ho, I. A. W., & SHIM, W. S. N. (2017) · BioMed Research International · doi:10.1155/2017/9634172 · Cited by 73
“periostin, that recruit and support the growth ofmacrophages through integrinαvβ3 [160].”
BackgroundYou, H., Baluszek, S., & Kaminska, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01941 · Cited by 76
“Several tumor-secreted factors such as osteopontin/SPP1 (19), versican (20), and periostin (21) have been reported as factors promoting re-education of microglia and macrophages infiltrating TME and therefore, shaping immune microenvironment of malignant gliomas.”
BackgroundLiao, Y., Li, G., Zhang, X., Huang, W., Xie, D., Dai, G., Zhu, S., Lu, D., Zhang, Z., Lin, J., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.011 · Cited by 68
“Zhou et al.(47) previously reported that POSTN secreted by GSCs could recruit M2 type TAMs through integrin aVb3 signaling to support glioblastoma multiforme (GBM) growth, but they not claim whether POSTN modulates the polarization of macrophages.”
BackgroundInfluentialBiomarkers and severe asthma: a critical appraisal
Chiappori, A., Ferrari, L. D., Folli, C., Mauri, P., Riccio, A., & Canonica, G. W. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0027-7 · Cited by 72
Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells
Lambert, A. W., Wong, C. K., Ozturk, S., Papageorgis, P., Raghunathan, R., Alekseyev, Y. O., Gower, A. C., Reinhard, B. M., Abdolmaleky, H. M., & Thiagalingam, S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0079 · Cited by 68
“Similarly, POSTNhas recently been reported to be secreted by glioblastoma stem cells (53).”
NFκB-Induced Periostin Activates Integrin-β3 Signaling to Promote Renal Injury in GN
Prakoura, N., Kavvadas, P., Kormann, R., Dussaule, J., Chadjichristos, C. E., & Chatziantoniou, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070709 · Cited by 63
Jia, X.-H., Feng, G.-W., Wang, Z.-L., Du, Y., Shen, C., Hui, H., Peng, D., Li, Z.-J., Kong, D.-L., & Tian, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8064 · Cited by 62
“Additionally, macrophages are the main cells in the tumor microenvironment [27].”
Chen, J., Zhao, D., Zhang, L., Zhang, J., Xiao, Y., Wu, Q., Wang, Y., & Zhan, Q. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00903-z · Cited by 71
“DISCUSSION The interaction between TAMs and tumor cells is pivotal for tumor malignancy [22, 43, 44].”
BackgroundExosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
Luo, H., Zhang, H., Mao, J., Cao, H., Tao, Y., Zhao, G., Zhang, Z., Zhang, N., Liu, Z., Zhang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05753-9 · Cited by 68
“It acts as a chemoattractant by stimulating the integrin receptor αvβ3 of the peripheral monocytes and M2-like TAMs [107].”
BackgroundInfluentialTumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
Guo, Q., Zhou, Y., Xie, T., Yin, Y., Li, H., Shi, W., Zheng, L., Li, X., & Zhang, W. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.024 · Cited by 80
“326 Fifth, targeting CSCs by immunotherapy has been largely reported as CSCs contribute to tumor development indirectly by attenuating immune surveillance within the TME.”
BackgroundCAR T cells targeting α v β 3 integrin are effective against advanced cancer in preclinical models
Wallstabe, L., Mades, A., Frenz, S., Einsele, H., Rader, C. M., & Hudecek, M. (2018) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.11 · Cited by 63
Nakazawa, Y., Taniyama, Y., Sanada, F., Morishita, R., Nakamori, S., Morimoto, K., Yeung, K. T., & Yang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22340-7 · Cited by 65
Bao, L., & Li, X. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03571-2 · Cited by 65
Cancer stem cells: Recent insights and therapies
Zhou, H., Tan, L., Liu, B., & Guan, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115441 · Cited by 73
The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
Ren, J., Xu, B., Ren, J., Liu, Z., Cai, L., Zhang, X., Wang, W., Li, S., Jin, L., & Ding, L. (2023) · Brain Sciences · doi:10.3390/brainsci13091269 · Cited by 69
Allard, D., Wang, Y., Li, J. J., Conley, B. E., Xu, E., Sailer, D., Kimpston, C. N., Notini, R., Smith, C.-J., Köseoğlu, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99308 · Cited by 59
“POSTN regulates various cytokines and chemokines including TNF-α in skin inflammation and following spinal cord injury (21, 23); IL-1A, granulocyte-macrophage– CSF (GM-CSF), and the chemokine ligand CCL17 in allergic skin inflammation and glioblastoma (21, 54); RANTES (CCL5) in kidney and nasal epithelia (22, 66); and…”
BackgroundInfluentialInterleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages
Zhou, T., Zhou, Y., Qian, M., Fang, Y.-Z., Ye, S., Xin, W., Yang, X., & Wu, H. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.07.013 · Cited by 62
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
Gargini, R., Segura‐Collar, B., & Gómez, P. S. (2020) · Cancers · doi:10.3390/cancers12061622 · Cited by 64
“In a similar way, periostin has been associated with the recruitment of M2 macrophages, which in turn stimulates the growth of cells with glioma stem characteristics [104].”
BackgroundVitamin D Enhances Hematoma Clearance and Neurologic Recovery in Intracerebral Hemorrhage
Liu, J., Li, N., Zhu, Z., Kiang, K. M. Y., Ng, A. C. K., Dong, C. M., & Leung, G. (2022) · Stroke · doi:10.1161/strokeaha.121.037769 · Cited by 62
Bayerl, S., Niesner, R. A., Cseresnyés, Z., Radbruch, H., Pohlan, J., Brandenburg, S., Czabanka, M., & Vajkoczy, P. (2016) · Glia · doi:10.1002/glia.22994 · Cited by 63
“There are several studies that show an infiltration of monocyte-derived macrophages in experimental gliomas (Feng et al., 2015; Zhou et al., 2015).”
BackgroundJiang, Y., Liang, X., Han, Z., Wang, W., Xi, S., Li, T., Chen, C., Yuan, Q., Li, N., Yu, J., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00065-0 · Cited by 58
Current Advances and Challenges in Radiomics of Brain Tumors
Yi, Z., Long, L., Zeng, Y., & Liu, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.732196 · Cited by 70
Mechanism of cancer stemness maintenance in human liver cancer
Liang, N. N., Yang, T., Huang, Q., Yu, P., Liu, C., Chen, L., Wang, Q., Wang, G., & He, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04848-z · Cited by 62
“Crosstalk between TAMs and CSCs has been found in a variety of cancers, including glioblastoma, pancreatic ductal adenocarcinoma and so on [87].”
BackgroundZhou, Y., Guo, Y., Chen, L., Zhang, X., Wu, W., Zhi-min, Y., Li, X., Wang, Y., Hu, Z., & Wang, Z. (2022) · Theranostics · doi:10.7150/thno.73104 · Cited by 61
“In GBM, up to one-half of the cells of the tumor mass are tumor-associated macrophages and microglia (TAMs), which exert a tumor-supportive role in GBM progression and inversely correlate with GBM prognosis [9, 10].”
BackgroundCDC20 maintains tumor initiating cells
Xie, Q., Wu, Q., Mack, S. C., Yang, K., Kim, L., Hubert, C. G., Flavahan, W. A., Chu, C., Bao, S., & Rich, J. N. (2015) · Oncotarget · doi:10.18632/oncotarget.3676 · Cited by 57
“TICs have generated a substantial interest due to their resistance to conventional therapies, evasion of anti-tumor immune responses, promotion of tumor angiogenesis and invasion [4, 5, 6, 7, 8, 9, 10].”
BackgroundThe Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
Audia, A., Conroy, S., Glaß, R., & Bhat, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00143 · Cited by 62
“TAMs in GBM have been shown to be recruited by periostin, a protein preferentially expressed by GSCs [77].”
BackgroundZhu, C., Zou, C., Guan, G., Guo, Q., Yan, Z., Liu, T., Shen, S., Xu, X., Chen, C., Lin, Z., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1621677 · Cited by 63
“Many researches had indicated that glioma prefer to termed as a “cold tumor” with low content of CD8 + T cells and M1 polarized macrophages, which exert critical roles in the regulating of immune cytolysis ability.(2,54,55) We also found that the number of CD8 + T cells was inversely correlated with tumor grade and su…”
BackgroundChaperone-assisted E3 ligase CHIP: A double agent in cancer
Kumar, S., Basu, M., & Ghosh, M. K. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.003 · Cited by 60
Faisal, S. M., Comba, A., Varela, M. L., Argento, A. E., Brumley, E. K., Abel, C. C., Castro, M. G., & Lowenstein, P. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005069 · Cited by 62
“Neutrophils promote the proliferation of GSCs with mesenchymal phenotypes (67) and GSCs recruited through TGF-b secretion induce an immunosuppressive and, protumoral M2 phenotype in macrophages (68, 69).”
BackgroundYuan, W., Zhang, Q., Gu, D., Lu, C., Dixit, D., Gimple, R. C., Gao, Y., Gao, J., Li, D., Shan, D., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3273 · Cited by 66
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Novel insights in the regulation and function of macrophages in the tumor microenvironment
Bolli, E., Movahedi, K., Laoui, D., & Van Ginderachter, J. A. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000344 · Cited by 57
Xue, H., Veit, C., Abas, L., Tryfona, T., Maresch, D., Ricardi, M. M., Estevez, J. M., Strasser, R., & Seifert, G. J. (2017) · The Plant Journal · doi:10.1111/tpj.13591 · Cited by 57
“…proteins function in cell to ECM adhesion, as ECM structural elements, in glucosaminoglycan serum clearance, as paracrine signals and in signal perception and they interact with ECM receptors of the integrin family (Kim et al., 2000; Harris et al., 2008; Zhou et al., 2015; Bonnet et al., 2016).”
BackgroundBeyond adhesion: emerging roles for integrins in control of the tumor microenvironment
Longmate, W. M., & DiPersio, C. M. (2017) · F1000Research · doi:10.12688/f1000research.11877.1 · Cited by 62
“For example, a recent study in a glioblastoma multiforme model showed that treatment with an RGD peptide also inhibits α v β 3 on TAMs, restricting their recruitment to the TME 91 .”
BackgroundResultPrognostic Gene Discovery in Glioblastoma Patients using Deep Learning
Wong, K., Rostomily, R., & Wong, S. T. C. (2019) · Cancers · doi:10.3390/cancers11010053 · Cited by 63
“POSTN is secreted by glioblastoma stem cells to recruit tumor-associated macrophages in order to promote malignant growth [28] and regulate tumor resistance to anti-angiogenic therapy [29].”
BackgroundOrigin, activation, and targeted therapy of glioma-associated macrophages
Xu, C., Xiao, M., Li, X., Lei, X., Song, J. L., Qi, Z., Wang, C., Zhang, Q., Yuan, X., Tan, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974996 · Cited by 65
Microglia immunophenotyping in gliomas
Annovazzi, L., Mellai, M., Bovio, E., Mazzetti, S., Pollo, B., & Schiffer, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.7386 · Cited by 63
“Glioma cells would establish an immunosuppressive tumor environment, promoting GAM recruitment and proliferation, polarizing them toward the M2 phenotype and remaining unaffected by their phagocyting and anti-tumorigenic functions (16,19-29).”
Zhang, Y., Feng, J., Fu, H., Liu, C., Yu, Z., Sun, Y., She, X., Li, P., Zhao, C., Liu, Y., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01557 · Cited by 55
Farha, M. W., Jairath, N. K., Lawrence, T. S., & Naqa, I. E. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00077 · Cited by 59
Stemness in solid malignancies: coping with immune attack
Agudo, J., & Miao, Y. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00760-0 · Cited by 72
“Recent studies have begun using immune-competent mice to investigate stemness-regulated immune resistance 86,87 , although most still rely on transplanted tumour models.”
Morisse, M. C., Jouannet, S., Dominguez‐Villar, M., Sanson, M., & Idbaïh, A. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1510321 · Cited by 60
“periostin), in the perivascular niche [79].”
Luo, S., Yang, G., Ye, P., Cao, N., Chi, X., Yang, W., & Yan, X. (2022) · Biomolecules · doi:10.3390/biom12060850 · Cited by 62
“POSTN 14 Integrinαvβ3 Glioblastoma Not shown [69]”
BackgroundCancer cell intrinsic TIM-3 induces glioblastoma progression
Guo, Q., Shen, S., Guan, G., Zhu, C. Y., Zou, C., Cao, J., Cheng, W., Xu, X., Yu, J., Lin, Z., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105329 · Cited by 60
Zhao, L., Qiu, Z., Yang, Z., Xu, L., Pearce, T. M., Wu, Q., Yang, K., Li, F.-L., Saulnier, O., Fei, F., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00658-0 · Cited by 66
“In contrast, GSCs actively remodel their microenvironment through secreted factors and bidirectional cell–cell communication 9,10 .”
Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth
Zhou, W., Cheng, L., Shi, Y., Ke, S. Q., Huang, Z., Fang, X., Chu, C.-W., Xie, Q., Bian, X., Rich, J. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5836 · Cited by 59
“GSCs were validated for their capacity of serial sphere formation, in vitro induction of differentiation and in vivo tumor propagation as previously described [3, 14, 57].”
MethodThe Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Movahedi, K., & Van Ginderachter, J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6704 · Cited by 53
“For example, in glioblastoma tumors, TAMs have been suggested to be either mainly derived from resident microglia (101) or to have an exclusively monocyte-derived peripheral origin (168).”
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.